Carcinoma rinofaringeo. Un tumore della testa e collo “diverso”. Parte B: trattamento, fattori prognostici e risultati a distanza
Author:
Publisher
Pacini Editore
Subject
General Earth and Planetary Sciences,General Environmental Science,Otorhinolaryngology
Reference98 articles.
1. Sun XS, Li XY, Chen QY, et al. Future of radiotherapy in nasopharyngeal carcinoma. Br J Radiol 2019;92:20190209. https://doi.org/10.1259/bjr.20190209
2. Cellai E, Chiavacci A, Olmi P, et al. Carcinoma of the nasopharynx: results of radiation therapy. Acta Radiol Oncol 1982;21:87-95. https://doi.org/10.3109/02841868209133989
3. Lee AW, Foo W, Law SC, et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J 1997;3:355-361.
4. Du T, Xiao J, Qiu Z, et al. Wu K. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis. PLoS One 2019;14:E0219611. https://doi.org/10.1371/journal.pone.0219611
5. Kong FF, Ying H, Du CR, et al. Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma. PLoS One 2014;9:E91362. https://doi.org/10.1371/journal.pone.0091362
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023;Biomedicines;2024-09-02
2. Recent advances in early detection of nasopharyngeal carcinoma;Discover Oncology;2024-08-23
3. Conundrum of 3N: nasopharyngeal nonkeratinizing non-viral carcinoma—reappraisal of fusions and report of two consecutive cases with unusual molecular findings;Virchows Archiv;2024-07-18
4. TPF induction chemotherapy versus PF adjuvant chemotherapy plus concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: a multicenter, randomized controlled phase III trial;2024-04-26
5. The use of adjuvant chemotherapy combined with concurrent chemoradiotherapy enhances survival rates in cases of locally advanced nasopharyngeal carcinoma;American Journal of Cancer Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3